Study of GBT021601 in Participants With Renal Impairment

Summary

Renal Impairment study of GBT021601.

Timeline

Start

2023-06-29

Primary completion

2024-07-29

Completion

2024-07-29

Outcome

Outcome not reported

Stopped (Business): “Business decision to terminate the trial after the completion of Part 1: Cohort 1 (severe renal impairment). The decision to terminate the trial was not due to any potential safety concerns.”

Drugs

Indications